Headline
** Teletalk owes govt Tk 1695cr ** Imported meat causes threat to public health ** Survivors give harrowing accounts ** Death toll crosses 5100 ** UN chief fears world is heading toward a wider war ** ‘IMF loan programme can be touchstone of financial sector reforms’ ** Wayfarers walk taking risks over a wide drain at Kakrail area in the capital on Tuesday, as construction work is going on there slowly. NN photo ** Covid tests begins with home made kit ** HSC results to be published today ** Turkey declares state of emergency for quake zone ** Slow place in Dhaka’s canals demarcation not acceptable ** Powerful earthquakes jolt Turkey and Syria ** Apparel sector eyes $15b Indian raw material support ** Belgium's Queen Mathilde Marie Christine visits corporate building, production house, day-care centre and different parts of knit composite manufacturing company Fakir Apparels Limited in Narayanganj district on Monday. PID photo ** President and PM express shock over quake in Turkey, Syria ** DB's final report clears Bushra, settles on suicide ** Turkey earthquake is country's worst disaster in 84 years: Erdogan ** IMF’s loan condition Additional Tk 65,000cr to be collected next year ** Major earthquake in Turkey, Syria kills nearly 2,300 people ** Bangladesh not sure to what end Indo-Bangladesh friendship is leading under Mr Modi's anti-Muslim stance ** PATHETIC INDEED! Geeta Biswas, a poor woman, failed to purchase OMS (open market sale) rice after standing in a long queue for hours. At last, she climbed into the truck for rice. When she tried to pick up the scattered rice in bags from the truck, the sellers took away the bags from her. Later she picked and took about one and a half kilos of rice. This photo was taken from Agrabad Government Commerce College area in Chattogram on Sunday. Agency photo ** Sending migrant workers BD-Malaysia agree to review MoU signed in 2021 ** Draft data protection law is a matter of concern: US envoy ** Pakistani former President Pervez Musharraf dies ** GDP growth in FY22 reaches 7.10pc **

India bars company from exporting vaccines

04 January 2021


AP, New Delhi :
India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday.
With rich nations reserving most of the vaccines that will be made this year, Serum Institute - the world's largest vaccine manufacturer - is likely to make most of the inoculations for developing countries. The ban on exports, however, means that poorer nations will probably have to wait a few months before receiving their first shots.
The vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn't export the shots to ensure that vulnerable populations in India are protected, Adar Poonawalla, the company's CEO, said in a phone interview with The Associated Press.
He said that the company also has been barred from selling the vaccine on the private market.
"We can only give (the vaccines) to the government of India at the moment," Poonawalla said, adding the decision was also made to prevent hoarding.
As a result, he said, the export of vaccines for COVAX - the ambitious initiative created to ensure equitable access to COVID-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics - won't begin until March or April.
Poonawalla said that Serum Institute was currently in the process of signing a larger contract with COVAX for 300-400 million doses of the vaccine. That is apart from two existing orders of 100 million doses each for the vaccine developed by Oxford University and AstraZeneca, and another one from Novovax. He said the deal would be finalized in the coming weeks.
He said the first 100 million doses of the vaccine were being sold to the Indian government at a "special price" of 200 rupees ($2.74) per dose, after which prices would be higher. The vaccine will be sold on the private market at 1,000 rupees ($13.68) per dose. He said vaccines could be delivered to Indian states where they were needed within seven to 10 days of the company finalizing a deal with India's government.
Poonawalla said his company was planning to give 200 to 300 million doses of the vaccine to COVAX by December 2021. He acknowledged that the company would have to balance distribution of vaccines between India and COVAX.
"We can't vaccinate everybody right now. We can prioritize," he said.
Serum Institute is also negotiating bilateral agreements with individual countries including Bangladesh, Saudi Arabia and Morocco, Poonawalla said. "So that at least the most vulnerable in the states of our country or in other parts of other countries are taken care off," he said.
Poonawalla said that even if all the plans by different global vaccine manufacturers were to succeed, he still anticipates a global shortage for coronavirus vaccines over the next year.

Add Rate